See our FAQs below for more information
Following the release of a drug, the FAERS database collects adverse events reports from providers and patients that are witnessed in-market (i.e., in the real world practice of medicine rather than during a clinical trial or drug testing process)
Tiny amounts, yes, but they accumulate
We integrate GLP-1 therapy with personalized nutritional counseling and lifestyle coaching, ensuring you lose fat while maintaining the vitality needed for a long-term lifestyle change
These models were fitted separately for each of the data sources (ie, CDM, MarketScan, and Medicare) and for each drug comparison (SGLT-2 inhibitors v DPP-4 inhibitors, GLP-1 receptor agonists v DPP-4 inhibitors, and SGLT-2 inhibitors v GLP-1 receptor agonists), for a total of nine propensity score models
By curbing hunger and creating a sense of fullness, Semaglutide has become a very popular choice for people who want to lose weight while also managing other health concerns, like type 2 diabetes